StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2023, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 25 Aug 2023 18:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html for the full story. http://www.streetinsider.com/Business+Wire/FSD+Pharma+Rebuts+Claims+of+GBB+Drink+Lab+now+acquired+by+Jupiter+Wellness+Inc.+Trading+under+the+symbol+%28NASDAQ%3A+JUPW%29/22092239.html Fri, 25 Aug 2023 18:16:00 -0400 0K9A HUGE JUPW O.39443675 O.48641143 Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Press+Releases/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html for the full story. http://www.streetinsider.com/Business+Wire/Arbitration+Panel+Finds+that+Syneos+Health+%28NASDAQ%3A+SYNH%29+Failed+to+Use+Commercially+Reasonable+Efforts+in+Conducting+its+Trial+for+FSD+201/21915471.html Mon, 17 Jul 2023 17:00:00 -0400 0K9A HUGE HUGE O.00186543 O.39443675 SYNH FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Mon, 10 Jul 2023 07:30:00 -0400 0K9A HUGE HUGE O.39443675 FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Mon, 10 Jul 2023 07:30:00 -0400 0K9A HUGE HUGE O.39443675 FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html for the full story. http://www.streetinsider.com/Press+Releases/FSD+Pharma+Retains+Christian+Attar+Law+and+Team+of+Experts+to+Lead+Preliminary+Investigation+of+Possible+Naked+Short+Selling+and+Manipulation+in+its+stock/21889621.html Mon, 10 Jul 2023 07:30:00 -0400 0K9A HUGE HUGE O.39443675